# Inpatient Blood Glucose Control in Taichung Veterans General Hospital

Study · id `cardio:ct-nct02885909` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02885909](<https://clinicaltrials.gov/study/NCT02885909>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02885909

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.

## Technical summary

Registry record NCT02885909. Non-randomized; no masking; primary purpose treatment. Start 2016-09 (registry gives no type); primary completion 2022-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT02885909, source copy `cardio:ctgov-nct02885909-2020-01-07`, retrieved 2026-10-26)
- Start date: 2016-09 (registry gives no type) (ClinicalTrials.gov record NCT02885909, source copy `cardio:ctgov-nct02885909-2020-01-07`, retrieved 2026-10-26)
- Primary completion: 2022-12 (anticipated) (ClinicalTrials.gov record NCT02885909, source copy `cardio:ctgov-nct02885909-2020-01-07`, retrieved 2026-10-26)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT02885909, source copy `cardio:ctgov-nct02885909-2020-01-07`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT02885909, source copy `cardio:ctgov-nct02885909-2020-01-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02885909-2020-01-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Inpatient Blood Glucose Control in Taichung Veterans General Hospital
- Condition: HYPERGLYCEMIA
- Intervention (Device): CONTINUE GLUCOSE MONITOR
- Intervention (Procedure): Insulin protocal
- Lead sponsor: Taichung Veterans General Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 304ac996decf5ecbab48236a42e31496727ba4877f6e9cd0eeb8c7b3df669a1f
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
